What Dhanvantari Solutions does

Dhanvantari Solutions is a Latvian private limited liability company (SIA "DHANVANTARI SOLUTIONS", reg. LV40103298493) founded in 2018 and headquartered in Riga, operating in the 11-50 employee range. The company describes itself as an IT and IT&T (information and communications technologies) innovator and is currently executing two active R&D projects rather than commercial product lines. OncoAIM is an AI-driven diagnostic solution that uses machine learning models trained on medical imaging (X-rays, ultrasonography) and structured clinical data to detect malignant tumors and metastases, deployed in a combined edge-cloud architecture and designed to be compatible with compact imaging equipment widely used in healthcare settings. FPV PLUS is a dual-use multirotor unmanned aerial vehicle (UAV) platform with an innovative data transmission system and ground station engineered for high radio interference and complex environment scenarios, targeting defense and security applications. Both products are at prototype/validation stages, with OncoAIM at TRL7.

The company's business model is overwhelmingly project-based and grant-funded: approximately €2.54 million of public support has been secured across the two projects from EU mechanisms (European Regional Development Fund and the EU Recovery and Resilience Mechanism / NextGenerationEU), with mandatory private co-financing. Revenue recognition depends on multi-year project execution (30 months for OncoAIM through December 2027; 24 months for FPV PLUS through August 2027). Dhanvantari serves healthcare providers (cancer diagnostics) and defense and security organizations (UAV communications) as primary verticals, with no disclosed commercial customers, no public pricing, and no distribution channels. Its core delivery partners are SIA DATI Group (OncoAIM) and SIA Redditum (FPV PLUS), supplemented by Swedish foreign partner DGR PRO AB on the defense project, and the OncoAIM work is positioned within the European IPCEI (Tech4Cure) strategic initiative.

Name

Dhanvantari Solutions

Legal name

SIA DHANVANTARI SOLUTIONS

Website

https://dsolutions.lv

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

Dhanvantari Solutions is a Latvian IT company (11-50 employees, founded 2018) developing AI-based cancer imaging diagnostics (OncoAIM) and a dual-use high-interference-resistant UAV platform (FPV PLUS) through EU-funded R&D partnerships with healthcare and defense clients.

Ownership category

akta.pro rank

Product category

AI Medical Imaging Software

NAICS

Scientific Research and Development Services (5417), Custom Computer Programming Services (541511), Computer Systems Design Services (541512)

SIC

Services-Computer Programming, Data Processing, Etc. (7370), Services-Computer Processing & Data Preparation (7374), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Medical Imaging AI (HDAAAEAH)

akta.pro secondary industries

SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG), Oncology Pathways & Precision Medicine Decision Support (HLACAGAH)

Keywords

• Medical imaging AI
• Cancer diagnostics software
• Drone communication systems
• Unmanned aerial platforms
• Defense technology

Headquarters

HQ city

Riga

HQ country

Latvia

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Marketing channels1 record

Core offering

Dhanvantari Solutions develops IT&T innovations through EU-funded R&D projects. The company is building OncoAIM, an AI-driven diagnostic solution for malignant tumor and metastasis detection using machine learning models trained on medical imaging data (X-rays, ultrasonography) in a combined edge-cloud architecture. It is also developing FPV PLUS, a dual-use multirotor UAV platform with a high radio interference-resistant data transmission system and ground station for defense and security applications.

Product overview

Dhanvantari Solutions is developing IT&T innovations through two active R&D projects. OncoAIM is an AI-driven medical diagnostic solution for malignant tumor and metastasis detection, using computer vision and generative AI trained on medical imaging data (X-rays, ultrasonography) in a combined edge-cloud architecture. FPV PLUS is a dual-use multirotor UAV platform with advanced data transmission capabilities designed for high-interference environments in defense and security applications. Both products are in active development phases with EU funding support.

Differentiator

Problem solved

Functional benefit

Products and services

• OncoAIM
• FPV PLUS

Quantifiable outcome

• Automated tumor and metastasis diagnostics to address healthcare workforce shortage
• +2 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature3 records

Partnerships

Three partnerships are on record, tiered core and minor.

• RedditumcoreStrategic or Co-development Partner · 1 September 2025SIA Redditum is a significant industry company in Latvia and the primary project applicant for the FPV PLUS dual-use multirotor drone platform development. Dhanvantari Solutions serves as the cooperation partner specializing in IT solutions for this 24-month project running from September 2025 to August 2027.
• DATI GroupcoreStrategic or Co-development Partner · 1 July 2025SIA DATI Group collaborates with Dhanvantari Solutions on the OncoAIM project for AI-powered tumor and metastasis diagnostic solution development. This 30-month project (July 2025 - December 2027) focuses on creating medical imaging AI tools compatible with compact imaging equipment widely used in the industry.
• DGR PRO ABminorStrategic or Co-development PartnerSwedish company providing foreign partner expertise in training, training and testing of various equipment. Contributes knowledge and expertise in solution requirement definition for the FPV PLUS drone communication project.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Aidence: Aidence (now part of Volpara Health) builds AI for oncology imaging — notably lung cancer CT screening — directly comparable to OncoAIM's AI-driven tumor and metastasis detection in X-ray and ultrasound. Both target radiologist shortages with regulatory-cleared AI diagnostic tools.
• Lunit: Lunit develops medical imaging AI for cancer detection (chest X-ray, mammography, pathology), closely matching OncoAIM's oncology imaging AI focus. Both compete in automating cancer diagnosis from radiologist-reviewed images using deep learning.
• Zebra Medical Vision (Nanox): Zebra Medical Vision (acquired by Nanox) developed AI algorithms for detecting multiple conditions including oncology findings across CT, X-ray, and mammography. Directly comparable in oncology imaging AI model training and clinical workflow integration.
• Aidoc: Aidoc provides AI-powered medical imaging analysis for radiologists across CT, X-ray, and MRI workflows. Comparable in deploying AI diagnostic models into clinical imaging pipelines and addressing specialist workload bottlenecks.
• Qure.ai: Qure.ai builds deep-learning models for radiology interpretation including chest X-ray, head CT, and lung nodule detection. Directly comparable AI imaging product set with focus on emerging-market and resource-limited deployment scenarios.
• Annalise.ai: Annalise.ai develops comprehensive AI models for chest X-ray and other radiology findings, with CE-marked products in European clinical use. Comparable in oncology-relevant imaging AI and European regulatory positioning.
• DeepHealth (RadNet subsidiary): DeepHealth, a RadNet subsidiary, develops AI for medical imaging interpretation across oncology and radiology workflows. Comparable in clinical AI imaging deployment targeting radiologist efficiency gains.

Broad incumbents

• Siemens Healthineers: Siemens Healthineers offers AI-augmented imaging solutions (AI-Rad Companion) as part of its broad medical imaging portfolio. Comparable as a broad incumbent whose AI imaging capabilities could partner with or compete against OncoAIM-style point solutions.
• GE HealthCare: GE HealthCare integrates AI imaging analytics across its installed base of CT, X-ray, and ultrasound systems. Comparable as a broad incumbent whose Edison platform competes in the same AI imaging decision-support category as OncoAIM.

Others

• Shield AI: Shield AI develops autonomous drone systems and AI pilot software for defense applications. Comparable as an adjacent player in AI-enabled defense UAV platforms targeting contested-environment operations, the same use case FPV PLUS addresses.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/DhanvantariSolutions
• LinkedInlinkedin.com/company/dhanvantari-solutions

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dhanvantari Solutions